Literature DB >> 29960881

Disadvantages of set length antibiotic treatment for pulmonary exacerbation.

Michael J Stephen1.   

Abstract

Mesh:

Substances:

Year:  2018        PMID: 29960881     DOI: 10.1016/S2213-2600(18)30266-2

Source DB:  PubMed          Journal:  Lancet Respir Med        ISSN: 2213-2600            Impact factor:   30.700


× No keyword cloud information.
  1 in total

1.  Duration of intravenous antibiotic therapy in people with cystic fibrosis.

Authors:  Linsey Abbott; Amanda Plummer; Zhe Hui Hoo; Martin Wildman
Journal:  Cochrane Database Syst Rev       Date:  2019-09-05
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.